Incidence of leukopenia after intraperitonealvscombined intravenous/intraperitoneal chemotherapy in pseudomyxoma peritonei
Author:
Publisher
Baishideng Publishing Group Inc.
Reference24 articles.
1. Early- and Long-Term Outcome Data of Patients With Pseudomyxoma Peritonei From Appendiceal Origin Treated by a Strategy of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
2. The Clavien-Dindo Classification of Surgical Complications
3. Risk factors for recurrence following complete cytoreductive surgery and HIPEC in colorectal cancer-derived peritoneal surface malignancies
4. Accuracy of MDCT in the preoperative definition of Peritoneal Cancer Index (PCI) in patients with advanced ovarian cancer who underwent peritonectomy and hyperthermic intraperitoneal chemotherapy (HIPEC)
5. Pseudomyxoma Peritonei Long-Term Patient Survival with an Aggressive Regional Approach
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Hematological Alterations after Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy;Journal of Clinical Medicine;2023-06-27
2. Predictive Ability of C-Reactive Protein in Detecting Short-Term Complications After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: A Retrospective Cross-Sectional Study;Annals of Surgical Oncology;2020-06-10
3. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy combined with liver resection for concurrent peritoneal and hepatic metastases of gastrointestinal and gynecological primary tumors;Journal of Visceral Surgery;2019-12
4. Chirurgie de cyto-réduction et chimio-hyperthermie intrapéritonéale combinées à une résection hépatique pour métastases péritonéales et hépatiques synchrones d’origine digestive ou gynécologique;Journal de Chirurgie Viscérale;2019-12
5. Thrombin generation and platelet activation in cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy - A prospective cohort study;PLOS ONE;2018-06-21
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3